Now, that really will be a waste of money initiated by the directors. If, indeed, there are any assets for the administrators to levy their fees against.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025